Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients

Figure 1

Increased IL-33 expression in gout patients with renal damage. (a) The serum levels of IL-33 in gout patients () and healthy controls (HC) () were detected by ELISA; each symbol represented an individual sample and horizontal lines showed median values. (b) The gout patients were divided into two groups, one group with kidney function injury () and one without (). Mann-Whitney test was conducted to compare the data between two groups.

(a)

(b)